Alumis ALMS
NASDAQ ALMS
$7.29 +0.13 (+1.82%)
At close: Sep 29, 2026 · 4:00 PM EDT

Alumis (ALMS) Common Equity (2023 - 2026)

Updated

Alumis' Common Equity came in at $452.16 million for Q2 2026, down 6.8% from $485.33 million a year earlier.

Analysis

Alumis (ALMS) Common Equity (2023 - 2026) Analysis & Trends

At the end of FY2025, Alumis' Common Equity was $301.3 million, up 15.8% from FY2024.

  • Going back by year, Common Equity was $260.1 million in FY2024 and -$339.26 million in FY2023.
  • The five-year range for quarterly Common Equity is -$438.76 million (Q2 2024) to $485.33 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Alumis 891.03 Mn -783.81 Mn - 452.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 452.16 Mn
Dec 31, 2025 301.30 Mn
Sep 30, 2025 384.77 Mn
Jun 30, 2025 485.33 Mn
Mar 31, 2025 168.31 Mn
Dec 31, 2024 260.10 Mn
Sep 30, 2024 348.39 Mn
Jun 30, 2024 -438.76 Mn
Mar 31, 2024 -385.93 Mn
Dec 31, 2023 -339.26 Mn
Sep 30, 2023 -303.07 Mn
Jun 30, 2023 -262.35 Mn
API Access

Alumis Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=ALMS&period=max&api_key=YOUR_API_KEY